Octreotide Industry Research Report 2024

Octreotide Industry Research Report 2024


Summary

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
According to APO Research, the global Octreotide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals and Yibin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide segment by Type

Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide segment by Application

Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Octreotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Octreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Octreotide Market Size (2019-2030) & (US$ Million)
2.2.2 Global Octreotide Sales (2019-2030)
2.2.3 Global Octreotide Market Average Price (2019-2030)
2.3 Octreotide by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Octreotide Injection
2.3.3 Octreotide Powder
2.3.4 Octreotide Microspheres
2.4 Octreotide by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Treating Severe Diarrhea
2.4.3 Treating Acromegaly
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Octreotide Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Octreotide Sales (Gram) of Manufacturers (2019-2024)
3.3 Global Octreotide Revenue of Manufacturers (2019-2024)
3.4 Global Octreotide Average Price by Manufacturers (2019-2024)
3.5 Global Octreotide Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Octreotide, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Octreotide, Product Type & Application
3.8 Global Manufacturers of Octreotide, Date of Enter into This Industry
3.9 Global Octreotide Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Novartis
4.1.1 Novartis Company Information
4.1.2 Novartis Business Overview
4.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Novartis Octreotide Product Portfolio
4.1.5 Novartis Recent Developments
4.2 Sun Pharmaceutical
4.2.1 Sun Pharmaceutical Company Information
4.2.2 Sun Pharmaceutical Business Overview
4.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sun Pharmaceutical Octreotide Product Portfolio
4.2.5 Sun Pharmaceutical Recent Developments
4.3 Chengdu Tiantaishan pharmaceutical
4.3.1 Chengdu Tiantaishan pharmaceutical Company Information
4.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
4.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
4.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
4.4 Sinopharm A-Think Pharmaceuticals
4.4.1 Sinopharm A-Think Pharmaceuticals Company Information
4.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
4.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
4.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
4.5 Sihuan Pharmaceutical Holdings Group
4.5.1 Sihuan Pharmaceutical Holdings Group Company Information
4.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
4.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
4.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
4.6 Shanghai Soho-Yiming Pharmaceuticals
4.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
4.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
4.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
4.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
4.7 Yibin Pharmaceutical
4.7.1 Yibin Pharmaceutical Company Information
4.7.2 Yibin Pharmaceutical Business Overview
4.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
4.7.5 Yibin Pharmaceutical Recent Developments
5 Global Octreotide Market Scenario by Region
5.1 Global Octreotide Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Octreotide Sales by Region: 2019-2030
5.2.1 Global Octreotide Sales by Region: 2019-2024
5.2.2 Global Octreotide Sales by Region: 2025-2030
5.3 Global Octreotide Revenue by Region: 2019-2030
5.3.1 Global Octreotide Revenue by Region: 2019-2024
5.3.2 Global Octreotide Revenue by Region: 2025-2030
5.4 North America Octreotide Market Facts & Figures by Country
5.4.1 North America Octreotide Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Octreotide Sales by Country (2019-2030)
5.4.3 North America Octreotide Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Octreotide Market Facts & Figures by Country
5.5.1 Europe Octreotide Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Octreotide Sales by Country (2019-2030)
5.5.3 Europe Octreotide Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Octreotide Market Facts & Figures by Country
5.6.1 Asia Pacific Octreotide Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Octreotide Sales by Country (2019-2030)
5.6.3 Asia Pacific Octreotide Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Octreotide Market Facts & Figures by Country
5.7.1 Latin America Octreotide Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Octreotide Sales by Country (2019-2030)
5.7.3 Latin America Octreotide Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Octreotide Market Facts & Figures by Country
5.8.1 Middle East and Africa Octreotide Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Octreotide Sales by Country (2019-2030)
5.8.3 Middle East and Africa Octreotide Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Octreotide Sales by Type (2019-2030)
6.1.1 Global Octreotide Sales by Type (2019-2030) & (Gram)
6.1.2 Global Octreotide Sales Market Share by Type (2019-2030)
6.2 Global Octreotide Revenue by Type (2019-2030)
6.2.1 Global Octreotide Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Octreotide Revenue Market Share by Type (2019-2030)
6.3 Global Octreotide Price by Type (2019-2030)
7 Segment by Application
7.1 Global Octreotide Sales by Application (2019-2030)
7.1.1 Global Octreotide Sales by Application (2019-2030) & (Gram)
7.1.2 Global Octreotide Sales Market Share by Application (2019-2030)
7.2 Global Octreotide Revenue by Application (2019-2030)
7.2.1 Global Octreotide Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Octreotide Revenue Market Share by Application (2019-2030)
7.3 Global Octreotide Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Octreotide Value Chain Analysis
8.1.1 Octreotide Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Octreotide Production Mode & Process
8.2 Octreotide Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Octreotide Distributors
8.2.3 Octreotide Customers
9 Global Octreotide Analyzing Market Dynamics
9.1 Octreotide Industry Trends
9.2 Octreotide Industry Drivers
9.3 Octreotide Industry Opportunities and Challenges
9.4 Octreotide Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings